Patience C. Ogbozor
Director/Board Member chez KID CASTLE EDUCATIONAL CORPORATION
Profil
Ms. Patience C.
Ogbozor is a President, Chief Executive Officer & Director at Cannabinoid Biosciences, Inc. She is on the Board of Directors at Opportunity Zone Capital LLC, GiveMePower Corp., Kid Castle Educational Corp., Video River Networks, Inc., Goldstein Franklin, Inc. and Cannabinoid Biosciences, Inc.
Postes actifs de Patience C. Ogbozor
| Sociétés | Poste | Début |
|---|---|---|
| KID CASTLE EDUCATIONAL CORPORATION | Director/Board Member | 23/10/2019 |
| GIVEMEPOWER CORPORATION | Director/Board Member | 01/12/2019 |
| VIDEO RIVER NETWORKS, INC. | Director/Board Member | 01/10/2019 |
Cannabinoid Biosciences, Inc.
 Cannabinoid Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Cannabinoid Biosciences, Inc. engages in the discovery, development, and commercialization of cannabinoid, cannabidiol, endocannabinoids, phytocannabinoids, and synthetic cannabinoids. It seeks to commercialize its products through collaborations with pharmaceutical companies for the specific treatments of diseases and medical conditions. The company was founded in May 2014 and is headquartered in Torrance, CA. | Chief Executive Officer | 01/11/2018 |
| Goldstein Franklin, Inc. | Director/Board Member | 01/06/2015 |
| Opportunity Zone Capital LLC | Director/Board Member | 18/02/2020 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| KID CASTLE EDUCATIONAL CORPORATION | Commercial Services |
| GIVEMEPOWER CORPORATION | Technology Services |
| VIDEO RIVER NETWORKS, INC. | Electronic Technology |
| Entreprise privées | 3 |
|---|---|
Cannabinoid Biosciences, Inc.
Cannabinoid Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Cannabinoid Biosciences, Inc. engages in the discovery, development, and commercialization of cannabinoid, cannabidiol, endocannabinoids, phytocannabinoids, and synthetic cannabinoids. It seeks to commercialize its products through collaborations with pharmaceutical companies for the specific treatments of diseases and medical conditions. The company was founded in May 2014 and is headquartered in Torrance, CA. | Health Technology |
| Goldstein Franklin, Inc. | |
| Opportunity Zone Capital LLC |
